Acadia Pharmaceuticals Inc., of San Diego, appointed Gudarz Davar executive vice president and head of research and development.
Eton Pharmaceuticals Inc., of Deer Park, Ill., appointed Ingrid Hoos senior vice president of scientific affairs.
Mannkind Corp., of Westlake Village, Calif., appointed Kevin Kaiserman vice president, medical affairs and safety.
Mersana Therapeutics Inc., of Cambridge, Mass., appointed Chuck Miller senior vice president of regulatory affairs.
Onconova Therapeutics Inc., of Newtown, Pa., appointed James J. Marino chair of its board.
Recce Pharmaceuticals Ltd., of Sydney, appointed James Graham CEO.
Turning Point Therapeutics Inc., of San Diego, appointed Kevan Shokat, Benjamin Cravatt, Natalia Jura and Michael Varney to its scientific advisory board. Shokat will serve as chair.
Xortx Therapeutics Inc., of Calgary, Alberta, appointed Ian Klassen to its board.